Extended-release guanfacine was found to be effective versus placebo in treating ADHD in children between 6 to 17 years old. Statistically significant mprovement was found on five assessment measures.
Non-stimulant found to be effective in treating ADHD
About the Author: Stephanie Sarkis
Dr. Stephanie Sarkis is a National Certified Counselor (NCC), Licensed Mental Health Counselor (LMHC), and AMHCA Diplomate and Clinical Specialist in Child and Adolescent Counseling based in Tampa Bay, Florida, where she specializes in the treatment of ADD/ADHD. Dr. Sarkis conducts evaluations, testing, diagnosis, and counseling services. She also is a public speaker, consultant, coach, and is a facilitator in collaborative law.